IMUX

Conviction 99HealthcareScan · Thu, Jun 25, 2026

Bullish harami

IMUX$15.09+2.58%

ResistanceSupportVol 14

Vol MA14 238.92K

Mar 26Apr 14May 1May 19Jun 8Jun 25

IMMUNIC, INC.PHARMACEUTICAL PREPARATIONSwww.imux.com ↗

Price15.09

Change+2.58%

Gap+1.09%

Rel volume1.95×

Avg volume248.51K

Avg $ vol3.5M

SMA 2013.99

SMA 5010.85

SMA 2003.34

Price vs 50+39.08%

Price vs 200+351.44%

MA stackbullish

50/200 cross—

Supertrendup · 11.60

RSI (14)65

MACD hist-0.06

MACD cross—

Stoch %K / %D91 / 88

ADX (14)42

+DI / −DI23 / 10

RSI divergenceBearish

MACD divergenceBearish

ATR %+7.42%

ADR %8.40%

52w high15.13

52w low0.5102

From 52w high-0.26%

Above 52w low+2857.66%

New 52w highYes

SqueezeOff

Bollinger width29.82%

%B0.76

Donchian pos83.89%

Donchian high15.77

Donchian low11.55

AVWAP (52w high)14.05

vs AVWAP high+7.42%

AVWAP (52w low)1.46

vs AVWAP low+936.08%

OBV trendUp

Chaikin MF (20)-0.04

Today vs 20d1.95×

Avg vol (14d)238.92K

Avg vol (20d)248.51K

Avg $ vol (20d)3.5M

Market cap205.55M

RS 3m (vs SPY)+1064.54%

RS 6m (vs SPY)+2459.45%

RS line new highNo

Trend template8/8

Technical rank95.6

1 week+6.27%

1 month+16.35%

3 months+1043.18%

6 months+2401.24%

1 year+2031.36%

YTD+2488.34%

P/E-2.12

P/B1.36

P/S—

P/FCF-2.39

EPS-0.6200

Div yield—

ROE-64.25%

ROA-51.21%

Debt/Eq—

Current4.92

EV/EBITDA-0.18

Gross margin—

Net margin—

Rev growth—

EPS growth3.32%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value18.92M

Revenue22K

Net income-32.59M

Gross profit9K

Free cash flow-85.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees95

ListedThu, Apr 17, 2014

Free float120.71M

Float %88.6%

Short interest1.76M

Days to cover6.6d

Short volume61.5%

Squeeze score56 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$1.24 · 6 est

Last EPS vs est−$1.08 vs −$0.71

Last surprise-52.1% miss

Setup gradeA+

Conviction99 / 100

Pattern quality—

Tech rank95.6 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMUX

All disclosures →

No recent disclosed trades by Congress in IMUX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMUX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Lundgren Erik Chief Executive Officer · Stock Option · 2026-05-22	Grant	1M	$0	2026-05-22	2026-06-01
Panzara Michael A. Chief Medical Officer · Stock Option · 2026-04-24	Grant	300K	$0	2026-04-24	2026-04-29

SEC filings

EDGAR filings in IMUX

EDGAR →

No recent SEC filings on file for IMUX.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.